Shares of biotech stock Zogenix had an exciting trading day on Friday after the company reported positive epilepsy drug test results. The company’s drug ZX008 succeeded in showing improvements in reducing seizures for patients that have Dravet syndrome in a Phase 3 trial. Shares increased by 180% in midday trading on Friday after the company … Continue reading “Zogenix Shares Double on Epilepsy Treatment Results”
Author: Sophia Vida
Whole Foods Has Been Hacked
After the Equifax data breach, the last thing many people want to read is about…
HSBC Is Fined $175 Million by the U.S. Federal Reserve
HSBC Holdings PLC has been slapped with a $175 million fine by the U.S. Federal…
Angry Birds Maker Gets A $1 Billion IPO Evaluation
The maker behind Angry Birds, Rovio Entertainment Ltd., has priced its initial public offering (IPO)…
Roku Shares Explode on First Day of Trading
Roku made its opening day debut in trading on the stock market on Thursday and…
The FDA Has Approved the First Finger Prick-Free Diabetes Device
Millions of Americans may be thrilled to learn that the Food & Drug Administration has…
Mark Zuckerberg Reacts to President Trump Saying Facebook is “Anti-Trump”
President Donald J. Trump took to his Twitter on Wednesday and said that Facebook, the…
Twitter Will Test 280-Character Limit But This is How You Can Already Do it
Twitter made a big announcement this week that it will be testing a character limit…
Macy’s Made a Big Move to Gain More Shoppers
Department store chain Macy's has reinvented its loyalty program in an effort to gain more…
Equifax CEO Steps Down In Midst of Major Data Breach
Equifax CEO and chairman, Richard Smith, has stepped down from both positions this week and…
Google To Split Off Its Shopping Service
According to reports, Alphabet's Google unit will later this week split off its shopping service…
Khloe Kardashian is Now the Third Kardashian Expecting a Child
The internet was floored last week when news outlets started reporting that Kylie Jenner is…
Target Will Raise its Minimum Wage to $15 By The End of 2020
There's more reasons to love Target right now. The retailer made a big announcement this…
Bristol-Myers Squibb Gets FDA Approval for its Liver Drug Opdivo
It was an exciting day for Bristol-Myers Squibb on Monday. The Food and Drug Administration…
